Demonstrated in vivo effect

Follow

Industry

CPC
C12N2770/36271

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2770/00ssRNA Viruses positive-sense

Current Industry

C12N2770/36271Demonstrated in vivo effect

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Live, attenuated rubella vector to express vaccine antigens
- Patent number 9,566,329
- Issue date Feb 14, 2017
- The United States of America, as represented by the Secretary, Department of...
- Ira Berkower
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
VACCINATION AGAINST JAPANESE ENCEPHALITIS, MEASLES, MUMPS AND RUBELLA
- Publication number 20150273035
- Publication date Oct 1, 2015
- Sanofi Pasteur
- Emmanuel Feroldi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LIVE, ATTENUATED RUBELLA VECTOR TO EXPRESS VACCINE ANTIGENS
- Publication number 20150079123
- Publication date Mar 19, 2015
- The United States of America, as represented by the Secretary, Dep. of Health...
- Ira Berkower
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...